Media coverage
69
Media coverage
Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet PR Newswire Country/Territory United States Date 21/06/23 URL https://www.prnewswire.com/news-releases/chemomab-therapeutics-reports-positive-data-from-secondary-analysis-of-phase-2a-liver-fibrosis-trial-in-nash-patients-at-easl-2023-301856160.html Persons Scott Friedman Title Chemomab Therapeutics (CMMB) Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial Media name/outlet Street Insider Country/Territory United States Date 21/06/23 URL https://www.streetinsider.com/Corporate+News/Chemomab+Therapeutics+%28CMMB%29+Reports+Positive+Data+from+Secondary+Analysis+of+Phase+2a+Liver+Fibrosis+Trial/21821441.html Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Street Insider Country/Territory United States Date 21/06/23 URL https://www.streetinsider.com/Press+Releases/Chemomab+Therapeutics+Reports+Positive+Data+from+Secondary+Analysis+of+Phase+2a+Liver+Fibrosis+Trial+in+NASH+Patients+at+EASL+2023/21821423.html Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet BioSpace Country/Territory United States Date 21/06/23 URL https://www.biospace.com/article/releases/chemomab-therapeutics-reports-positive-data-from-secondary-analysis-of-phase-2a-liver-fibrosis-trial-in-nash-patients-at-easl-2023/?s=68 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet ADVFN UK Country/Territory United Kingdom Date 21/06/23 URL https://uk.advfn.com/stock-market/NASDAQ/CMMB/share-news/Chemomab-Therapeutics-Reports-Positive-Data-from-S/91388029 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Yahoo! Finance Country/Territory United States Date 21/06/23 URL https://finance.yahoo.com/news/chemomab-therapeutics-reports-positive-data-110000126.html Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Spoke.com Country/Territory United States Date 21/06/23 URL https://www.spoke.com/press_releases/6492d911fcf26846dc00dfce Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Southwest Daily News Country/Territory United States Date 21/06/23 URL https://smb.southwestdailynews.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Greenville Business Magazine Country/Territory United States Date 21/06/23 URL https://pr.greenvillebusinessmag.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Canadian Insider Country/Territory Canada Date 21/06/23 URL https://www.canadianinsider.com/chemomab-therapeutics-reports-positive-data-from-secondary-analysis-of-phase-2a-liver-fibrosis-trial-in-nash-patients-at-easl-2023 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Investors Hub Country/Territory United Kingdom Date 21/06/23 URL https://ih.advfn.com/p.php?pid=nmona&article=91388029 Persons Scott Friedman Title Chemomab Therapeutics: Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 (Millistream) Media name/outlet Avanza Bank AB Country/Territory Sweden Date 21/06/23 URL https://www.avanza.se/placera/pressmeddelanden/2023/06/21/chemomab-therapeutics-chemomab-therapeutics-reports-positive-data-from-secondary-analysis-of-phase-2a-liver-fibrosis-trial-in-nash-patients-at-easl-2023.html Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Leesville Leader Country/Territory United States Date 21/06/23 URL https://smb.theleesvilleleader.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Riverton Journal Country/Territory United States Date 21/06/23 URL https://pr.rivertonjournal.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Clemmons Courier Country/Territory United States Date 21/06/23 URL https://smb.clemmonscourier.net/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet MillisMedway - Local Town Pages Country/Territory United States Date 21/06/23 URL https://pr.millismedwaynews.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet TheTidewaterNews.com Country/Territory United States Date 21/06/23 URL https://smb.thetidewaternews.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Ashland - Local Town Pages Country/Territory United States Date 21/06/23 URL https://pr.ashlandtownnews.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Lowndes Signal Country/Territory United States Date 21/06/23 URL https://smb.lowndessignal.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet ValleyTimes-News.com Country/Territory United States Date 21/06/23 URL https://smb.valleytimes-news.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Leader Publications Country/Territory United States Date 21/06/23 URL https://smb.leaderpub.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Luverne Journal Country/Territory United States Date 21/06/23 URL https://smb.luvernejournal.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Smithfield Times Country/Territory United States Date 21/06/23 URL https://smb.smithfieldtimes.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Middlesboro News Country/Territory United States Date 21/06/23 URL https://smb.middlesboronews.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Washington Daily News Country/Territory United States Date 21/06/23 URL https://smb.thewashingtondailynews.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Greenville Advocate Country/Territory United States Date 21/06/23 URL https://smb.greenvilleadvocate.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Jessamine Journal Country/Territory United States Date 21/06/23 URL https://smb.jessaminejournal.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet BluegrassLive.com Country/Territory United States Date 21/06/23 URL https://smb.bluegrasslive.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Andalusia Star Country/Territory United States Date 21/06/23 URL https://smb.andalusiastarnews.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Roanoke Chowan News Herald Country/Territory United States Date 21/06/23 URL https://smb.roanoke-chowannewsherald.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Bogalusa Daily News Country/Territory United States Date 21/06/23 URL https://smb.bogalusadailynews.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Stanly News & Press Country/Territory United States Date 21/06/23 URL https://smb.thesnaponline.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Holliston - Local Town Pages Country/Territory United States Date 21/06/23 URL https://pr.hollistontownnews.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Hopedale - Local Town Pages Country/Territory United States Date 21/06/23 URL https://pr.hopedaletownnews.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Norwood - Local Town Pages Country/Territory United States Date 21/06/23 URL https://pr.norwoodtownnews.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Salisbury Post Country/Territory United States Date 21/06/23 URL https://smb.salisburypost.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Atmore Advance Country/Territory United States Date 21/06/23 URL https://smb.atmoreadvance.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Magnolia State Live Country/Territory United States Date 21/06/23 URL https://smb.magnoliastatelive.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Davie County Enterprise Record Country/Territory United States Date 21/06/23 URL https://smb.ourdavie.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet NorfolkWrentham - Local Town Pages Country/Territory United States Date 21/06/23 URL https://pr.norfolkwrenthamnews.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Demopolis Times Country/Territory United States Date 21/06/23 URL https://smb.demopolistimes.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Orange Leader Country/Territory United States Date 21/06/23 URL https://smb.orangeleader.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Kenbridge Victoria Dispatch Country/Territory United States Date 21/06/23 URL https://smb.kenbridgevictoriadispatch.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Farmville Herald Country/Territory United States Date 21/06/23 URL https://smb.farmvilleherald.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Daily Leader.com Country/Territory United States Date 21/06/23 URL https://smb.dailyleader.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Charlotte Gazette Country/Territory United States Date 21/06/23 URL https://smb.thecharlottegazette.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Clanton Advisor Country/Territory United States Date 21/06/23 URL https://smb.clantonadvertiser.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Interior Journal Country/Territory United States Date 21/06/23 URL https://smb.theinteriorjournal.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Chester County Press (Oxford, Pennsylvania) Country/Territory United States Date 21/06/23 URL https://pr.chestercounty.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Shelby County Reporter Country/Territory United States Date 21/06/23 URL https://smb.shelbycountyreporter.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Cordele Dispatch Country/Territory Georgia Date 21/06/23 URL https://smb.cordeledispatch.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Troy Messenger Country/Territory United States Date 21/06/23 URL https://smb.troymessenger.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Austin Daily Herald Country/Territory United States Date 21/06/23 URL https://smb.austindailyherald.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Prentiss Headlight Country/Territory United States Date 21/06/23 URL https://smb.prentissheadlight.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Times of San Diego Country/Territory United States Date 21/06/23 URL https://pr.timesofsandiego.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet L' Observateur Country/Territory United States Date 21/06/23 URL https://smb.lobservateur.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Coastland Times Country/Territory United States Date 21/06/23 URL https://smb.thecoastlandtimes.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Elizabethton.com Country/Territory United States Date 21/06/23 URL https://smb.elizabethton.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Vicksburg Post Country/Territory United States Date 21/06/23 URL https://smb.vicksburgpost.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet The Brewton Standard Country/Territory United States Date 21/06/23 URL https://smb.brewtonstandard.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Claiborne Progress Country/Territory United States Date 21/06/23 URL https://smb.claiborneprogress.net/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Franklin- Local Town Pages Country/Territory United States Date 21/06/23 URL https://pr.franklintownnews.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Americus Times-Recorder Country/Territory Georgia Date 21/06/23 URL https://smb.americustimesrecorder.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Post-Searchlight Country/Territory Georgia Date 21/06/23 URL https://smb.thepostsearchlight.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Alabama Now Country/Territory United States Date 21/06/23 URL https://smb.alabamanow.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Gates County Index Country/Territory United States Date 21/06/23 URL https://smb.gatescountyindex.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Suffolk News Herald Country/Territory United States Date 21/06/23 URL https://smb.suffolknewsherald.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Alexander City Outlook Country/Territory United States Date 21/06/23 URL https://smb.alexcityoutlook.com/article/Chemomab-Therapeutics-Reports-Positive-Data-from-Secondary-Analysis-of-Phase-2a-Liver-Fibrosis-Trial-in-NASH-Patients-at-EASL-2023?storyId=6492d8cbf55e077dae984a21 Persons Scott Friedman Title Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 Media name/outlet Central Charts Country/Territory France Date 21/06/23 URL https://www.centralcharts.com/en/news/4286377-chemomab-therapeutics-reports-positive-data-from-secondary-analysis-of-phase-2a-liver-fibrosis-trial-in-nash-patients-at-easl-2023 Persons Scott Friedman